Skip to Main Content

DocGo Inc. (NASDAQ: DCGO) SECURITIES FRAUD INVESTIGATION

Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of DocGo Inc. (NASDAQ: DCGO) ("DocGo") securities between November 15, 2021 and January 9, 2024.

On January 10, 2024, before the market opened, market analyst Fuzzy Panda released a report on DocGo titled, “DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents.” Specifically, Fuzzy Panda found that “through former employee interviews and never before seen lawsuits we discovered serious allegations that DocGo (DCGO) has allegedly been committing Medicare fraud and having employees forge signatures on medical documents.”

Following this news, the price of DocGo stock fell over 30% during intraday trading, to close at $2.99 per share on January 10, 2024.   

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  

SUBMIT YOUR INFORMATION
* Denotes required field
Purchase(s)
+ Additional Purchases
Sale(s)
+ Additional Sales
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of DocGo Inc. prior to the Class Period?
Are you a current or former employee of DocGo Inc.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email
Submit Your Information